ChoiceSpine Launches Biologics Portfolio at National Sales Meeting

ChoiceSpine Biologics Portfolio

We are extremely excited about the launch of our Biologics Portfolio. We wanted to come out of the gate strong so we are proud to have an offering that includes various allograft and synthetic bone graft options in addition to a full amnion offering.

ChoiceSpine™, a privately-held spinal device manufacturer based in Knoxville, TN, launched its new biologics portfolio at its National Sales Meeting last week in Nashville, TN.

“We are extremely excited about the launch of our Biologics Portfolio. We wanted to come out of the gate strong so we are proud to have an offering that includes various allograft and synthetic bone graft options in addition to a full amnion offering,” commented Christy Cote, Vice President of Biologics and ChoiceSpine’s Tissue Bank Director. “We believe the addition of a biologics platform to our already strong product portfolio is an important strategic milestone.”

The Biologics product portfolio is marketed under two brands named after the Stratotanker™ plane that refuels military aircraft inflight. STRATOFUSE™ was designed to fuel fusion in spine and orthopedic surgical procedures. The STRATOFUSE brand will promote demineralized bone allograft putties and sponges, synthetic bone graft substitute putties and strips, structural allograft and allograft bone extenders. The STRATOGEN™ line will focus on a full amnion offering.

“STRATOFUSE and STRATOGEN exemplify our dedication to developing and distributing spinal products that are innovative and surgeon-focused,” said Rick Henson and Marty Altshuler, co-founders of ChoiceSpine. “We look forward to continuing to serve our surgeon customers with innovative products that deliver excellent…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *